MiniMed announced the commercial launch in Europe of both the MiniMed 780G system integrated with the Instinct sensor and the MiniMed Go system integrated with the Instinct Go sensor. The Instinct and Instinct Go sensors, made by Abbott, will be rolled out gradually across Europe starting this month, expanding MiniMed's sensor portfolio in the region.
The MiniMed 780G system includes Meal Detection technology designed to reduce post-meal blood glucose spikes when users occasionally forget to bolus or underestimate carbs. It pairs with the 15-day Instinct sensor. Recent data from a new randomized crossover study, published in Diabetes Technology & Therapeutics, demonstrated glycemic outcomes were virtually identical when using the MiniMed 780G system with either the Simplera Sync sensor or Instinct sensor. These results were reinforced by a real-world analysis of over 20,000 U.S. users of the MiniMed 780G system, validating the algorithm's central role in driving results.
The MiniMed Go system combines dose tracking with the InPen smart insulin pen and real-time CGM data, addressing the therapy adherence gap for MDI users by providing real-time alerts and actionable insights on a single mobile app when doses are missed or blood glucose spikes – helping MDI users stay on top of their diabetes with less effort.
